User Reviews for B-3-50

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Filter by:

Learn more about B-3-50.

Condition	Reviews	Compare	Avg. Ratings
Hyperlipoproteinemia	0 reviews	43 medications		8.0
High Cholesterol	0 reviews	40 medications	Not rated - Be the first
Hyperlipoproteinemia...V, Elevated VLDL	0 reviews	28 medications	Not rated - Be the first
Hyperlipoproteinemia...lomicrons VLDL	0 reviews	23 medications	Not rated - Be the first
Niacin Deficiency	0 reviews	11 medications	Not rated - Be the first
Pellagra	0 reviews	11 medications	Not rated - Be the first

Reviews for B-3-50

There are no reviews - Be the first

Related B-3-50 Information

Availability Rx and/or OTC

CSA Schedule Not a controlled drug

Pregnancy Category Risk cannot be ruled out

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Miscellaneous antihyperlipidemic agents
Vitamins

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

More...

Get Updates by Email

Email me about B-3-50:

Related News and Articles

Younger Adults on Multiple Meds at Risk for Falls: Study 17 January 2012
Young and middle-aged adults who take two or more prescription drugs at any one time may be at increased risk for accidental falls, a new study finds. The...
Spherix Announces Successful Completion of Important Toxicology Study of SPX-106 11 January 2012
Spherix Incorporated (NASDAQ: SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of...
Tekmira?s LNP Technology Enables Alnylam?s Positive ALN-PCS Clinical Data 5 January 2012
Vancouver B.C. – Tekmira Pharmaceuticals Corporation (Nasdaq: TKMR, TSX: TKM), a leading developer of RNA interference (RNAi) therapeutics, today...
Alnylam Reports Positive Preliminary Clinical Results for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia 4 January 2012
– RNAi Therapeutic Achieves Robust Silencing of PCKS9 and Reductions of Over 50% in LDL Cholesterol, a Validated Clinical Endpoint – – Results...
Health Tip: Improving Your Cholesterol 22 December 2011
High levels of LDL (the so-called "bad" cholesterol) or triglycerides puts you at higher risk of heart attack and stroke. While there's no surefire way to...

Help and Support

Looking for answers? Ask a question or go join the B-3-50 support group to connect with others who have similar interests.

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search:

User Reviews for B-3-50

Reviews for B-3-50

See also...

Related B-3-50 Information